Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1949 1
1950 1
1951 2
1952 1
1953 5
1954 3
1955 2
1956 2
1957 5
1958 3
1959 7
1960 6
1961 1
1962 13
1963 11
1964 17
1965 17
1966 4
1967 10
1968 8
1969 11
1970 9
1971 8
1972 10
1973 4
1974 6
1975 14
1976 7
1977 18
1978 13
1979 17
1980 11
1981 15
1982 16
1983 11
1984 20
1985 36
1986 45
1987 48
1988 70
1989 73
1990 70
1991 79
1992 90
1993 95
1994 111
1995 120
1996 146
1997 148
1998 175
1999 189
2000 216
2001 224
2002 270
2003 299
2004 387
2005 478
2006 552
2007 607
2008 682
2009 801
2010 950
2011 1081
2012 1157
2013 1355
2014 1422
2015 1381
2016 1470
2017 1534
2018 1688
2019 1835
2020 1981
2021 2179
2022 2437
2023 1019

Text availability

Article attribute

Article type

Publication date

Search Results

24,773 results

Results by year

Filters applied: . Clear all
Page 1
Cysteine carboxyethylation generates neoantigens to induce HLA-restricted autoimmunity.
Zhai Y, Chen L, Zhao Q, Zheng ZH, Chen ZN, Bian H, Yang X, Lu HY, Lin P, Chen X, Chen R, Sun HY, Fan LN, Zhang K, Wang B, Sun XX, Feng Z, Zhu YM, Zhou JS, Chen SR, Zhang T, Chen SY, Chen JJ, Zhang K, Wang Y, Chang Y, Zhang R, Zhang B, Wang LJ, Li XM, He Q, Yang XM, Nan G, Xie RH, Yang L, Yang JH, Zhu P. Zhai Y, et al. Among authors: chang y. Science. 2023 Mar 17;379(6637):eabg2482. doi: 10.1126/science.abg2482. Epub 2023 Mar 17. Science. 2023. PMID: 36927018
Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma.
Choueiri TK, Powles T, Albiges L, Burotto M, Szczylik C, Zurawski B, Yanez Ruiz E, Maruzzo M, Suarez Zaizar A, Fein LE, Schutz FA, Heng DYC, Wang F, Mataveli F, Chang YL, van Kooten Losio M, Suarez C, Motzer RJ; COSMIC-313 Investigators. Choueiri TK, et al. Among authors: chang yl. N Engl J Med. 2023 May 11;388(19):1767-1778. doi: 10.1056/NEJMoa2212851. N Engl J Med. 2023. PMID: 37163623 Clinical Trial.
What makes a good survey?
Chang Y, Wang L, Phillips MR, Wykoff CC, Garg SJ, Thabane L, Bhandari M, Chaudhary V; Retina Evidence and Trials INternational Alliance (R.E.T.I.N.A.) Study Group. Chang Y, et al. Eye (Lond). 2023 Apr 7. doi: 10.1038/s41433-023-02518-8. Online ahead of print. Eye (Lond). 2023. PMID: 37029303 No abstract available.
Fibula Jaw-during-Admission.
Chang YM, Tsai CY, Wei FC. Chang YM, et al. J Plast Reconstr Aesthet Surg. 2023 Feb 9;82:247-254. doi: 10.1016/j.bjps.2023.01.010. Online ahead of print. J Plast Reconstr Aesthet Surg. 2023. PMID: 37207438
Strategies for subtyping primary aldosteronism.
Yang YH, Chang YL, Lee BC, Lu CC, Wang WT, Hu YH, Liu HW, Lin YH, Chang CC, Wu WC, Tseng FY, Lin YH, Wu VC, Hwu CM. Yang YH, et al. Among authors: chang yl. J Formos Med Assoc. 2023 May 16:S0929-6646(23)00155-9. doi: 10.1016/j.jfma.2023.05.004. Online ahead of print. J Formos Med Assoc. 2023. PMID: 37202237 Free article. Review.
C-Reactive Protein: The Most Familiar Stranger.
Ji SR, Zhang SH, Chang Y, Li HY, Wang MY, Lv JM, Zhu L, Tang PMK, Wu Y. Ji SR, et al. Among authors: chang y. J Immunol. 2023 Mar 15;210(6):699-707. doi: 10.4049/jimmunol.2200831. J Immunol. 2023. PMID: 36881905 Review.
Current dental-associated professionals in Taiwan.
Lin MT, Huang FM, Chang YC. Lin MT, et al. Among authors: chang yc. J Dent Sci. 2023 Apr;18(2):923. doi: 10.1016/j.jds.2022.11.026. Epub 2022 Dec 8. J Dent Sci. 2023. PMID: 37021247 Free PMC article. No abstract available.
24,773 results
You have reached the last available page of results. Please see the User Guide for more information.